ARTEMISMEDBSEArtemis Medicare Services LtdMediumNeutral
Announced Sun, 10 May · 10:19 IST

Intimation regarding completion of tenure of an Independent Director

Management Changes View source PDF

ARTEMISMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.5%1-day move
₹266.00
prior close
₹272.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.3+2.7+3.3+3.8+1.5+3.8+4.2+5.4+2.3+5.3+2.3-4.5+4.7
Up moveDown movePending
AI summary

Artemis Medicare Services Ltd has announced that Mr. Sunil Tandon has ceased to be a Director of the Company upon completion of his tenure as an Independent Director on May 9, 2026. Mr. Tandon's DIN was 08342585. The company has filed this intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. No reason other than natural completion of tenure was cited. The disclosure was made on May 10, 2026.

Likely market impact

This is a routine governance event marking the natural end of an independent director's term. The company must ensure compliance with the requirement to have the required number of independent directors on the board. No immediate impact on stock price is expected, but shareholders should monitor for appointment of a replacement independent director.